Literature DB >> 9751130

Eph receptor-ligand interactions are necessary for guidance of retinal ganglion cell axons in vitro.

T Ciossek1, B Monschau, C Kremoser, J Löschinger, S Lang, B K Müller, F Bonhoeffer, U Drescher.   

Abstract

Previous results of an in vitro guidance test, the stripe assay, have demonstrated the presence of a repulsive axon guidance activity for temporal retinal axons in the posterior part of the vertebrate optic tectum. Ephrin-A5 and Ephrin-A2 are ligands for the EphA subfamily of Eph receptor tyrosine kinases, which are expressed in overlapping gradients in the posterior part of the tectum. When recombinantly expressed, both proteins have been shown to guide retinal ganglion cell axons in the stripe assay. While these results suggest that Ephrin-A5 and Ephrin-A2 form part of the posterior repulsive guidance activity, they do not elucidate whether they are necessary components. Here we report that soluble forms of the ligands at nanomolar concentrations completely abolish this repulsive activity. Similar results were obtained with the soluble extracellular domain of EphA3, which is a receptor for Ephrin-A2 and Ephrin-A5, but not with the corresponding domain of EphB3, a receptor for the transmembrane class of Eph ligands. These experiments show that the repulsive axon guidance activity seen in the stripe assay is mediated by Ephrin-A ligands.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9751130     DOI: 10.1046/j.1460-9568.1998.00180.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  16 in total

1.  Topographic-specific axon branching controlled by ephrin-As is the critical event in retinotectal map development.

Authors:  P A Yates; A L Roskies; T McLaughlin; D D O'Leary
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

Review 2.  Differential regulation of EphA2 in normal and malignant cells.

Authors:  Jennifer Walker-Daniels; Angela R Hess; Mary J C Hendrix; Michael S Kinch
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

3.  Src family kinases are involved in EphA receptor-mediated retinal axon guidance.

Authors:  Bernd Knöll; Uwe Drescher
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

4.  Loss-of-function analysis of EphA receptors in retinotectal mapping.

Authors:  David A Feldheim; Masaru Nakamoto; Miriam Osterfield; Nicholas W Gale; Thomas M DeChiara; Rajat Rohatgi; George D Yancopoulos; John G Flanagan
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

5.  Eph/ephrin interactions modulate muscle satellite cell motility and patterning.

Authors:  Danny A Stark; Rowan M Karvas; Ashley L Siegel; D D W Cornelison
Journal:  Development       Date:  2011-11-09       Impact factor: 6.868

6.  Polysialylated NCAM and ephrinA/EphA regulate synaptic development of GABAergic interneurons in prefrontal cortex.

Authors:  Leann H Brennaman; Xuying Zhang; Hanjun Guan; Jason W Triplett; Arthur Brown; Galina P Demyanenko; Paul B Manis; Lynn Landmesser; Patricia F Maness
Journal:  Cereb Cortex       Date:  2012-01-23       Impact factor: 5.357

7.  A unifying model for activity-dependent and activity-independent mechanisms predicts complete structure of topographic maps in ephrin-A deficient mice.

Authors:  Dmitry N Tsigankov; Alexei A Koulakov
Journal:  J Comput Neurosci       Date:  2006-07-05       Impact factor: 1.621

8.  Interaxonal Eph-ephrin signaling may mediate sorting of olfactory sensory axons in Manduca sexta.

Authors:  Megumi Kaneko; Alan Nighorn
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

9.  Ephrin-A5 restricts topographically specific arborization in the chick retinotectal projection in vivo.

Authors:  Takashi Sakurai; Eric Wong; Uwe Drescher; Hideaki Tanaka; Daniel G Jay
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-24       Impact factor: 11.205

10.  Gradients of Eph-A6 expression in primate retina suggest roles in both vascular and axon guidance.

Authors:  Peter Kozulin; Riccardo Natoli; Michele C Madigan; Keely M Bumsted O'Brien; Jan M Provis
Journal:  Mol Vis       Date:  2009-12-09       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.